New Resident Client at Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research

The inflammation COVID-19 patients suffer during and post-COVID-19 infection (AKA “Post-COVID Syndrome”) will be one of many focuses of a new resident client that recently joined the UF Innovate | Sid Martin Biotech, the world-recognized leader in biotechnology incubation. Neobiosis, which produces regenerative tissues, cells, and extracellular vesicles for research and clinical trials to help the body heal itself—without surgery—will operate a laboratory at the biotech center, located in Alachua.

Neobiosis’ Founder and Chief Scientific Officer Dr. Ian White, a renowned global expert in regenerative medicine research, is behind the new R&D laboratory. “We are honored to become a part of Sid Martin,” Dr. White said. “Few researchers are chosen, and for them to choose us means the world to our organization. The resources they provide will allow us to make great strides in the field of regenerative therapy.”

Read more about New Lab at UF’s Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research.